Status:
WITHDRAWN
Clinial Application of Park et al.(The Knee 27 (2020) 1577-1584)'s Study
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this study was to perform pulsed radiofrequency ablation with a modified target suggested in the cadaver study by Park et al. (The Knee 27 (2020) 1577-1584) on knee osteoarthritis patients...
Eligibility Criteria
Inclusion
- chronic knee pain that does not respond to conservative treatment (physiotherapy, oral analgesic, steroid intra-articular injection, Hyruan injection) for more than 6 months
- A score of 6 or higher (out of 10) on the target knee's numerical rating scale
- Knee osteoarthritis 1-4 confirmed in knee X ray within 6 months of study enrollment
Exclusion
- Systemic inflammatory diseases such as rheumatic diseases
- uncontrolled diabetes
- malignant tumor
- If the target knee has a previous surgical history (arthroscopy, arthroscopy, autologous or allograft osteochondral transplantation and autologous cartilage cell transplantation, osteotomy, arthritis surgery)
- Patients with lidocaine and contrast agent allergy
- history of nerve block in the target knee within 2 weeks
- Body mass index over 40 kg/m2
- bleeding disorder
- Pregnant/lactating women
- Inability to understand informed consent and respond to research questionnaires due to cognitive impairment
- Unable to read consent form (e.g. illiterate, foreigner, etc.)
Key Trial Info
Start Date :
December 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05202847
Start Date
December 7 2022
End Date
December 7 2022
Last Update
June 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.